Inception Return
(11/22/2007)
|
5.79 %
|
|
YTD Return
|
14.60 %
|
|
NAVPS
(9/5/2025)
|
$12.09
|
|
Change
|
$0.10 / 0.83 %
|
|
|
Growth of $10,000
(As of July 31, 2025)
|
|
MER
|
2.12 %
|
|
Assets ($mil)
|
$2,322.67
|
|
Rank (1Yr)
|
212/775
|
|
Std Dev (3Yr)
|
12.91 %
|
|
Volatility Ranking (3Yr)
|
6/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
-
|
|
Max Back End
|
6.00 %
|
|
Sales Status
|
Open
|
|
|
Objective
The NBI SmartData International Equity Fund’s investment objective is to provide long-term capital growth. This fund invests directly, or through investments in securities of other mutual funds, in a portfolio mainly composed of equities of foreign companies located outside of North America and in American Depositary Receipts (ADRs) traded on recognized stock exchanges.
|
Fund Manager
National Bank Investments Inc.
Portfolio Manager
Len Ioffe, Goldman Sachs Asset Management LP
Osman Ali, Goldman Sachs Asset Management LP
Dennis Walsh, Goldman Sachs Asset Management LP
Takashi Suwabe, Goldman Sachs Asset Management LP
Sub-Advisor
-
|
|
Asset Allocation
(As of July 31, 2025)
|
Sector Allocation
(As of July 31, 2025)
|
Geographic Allocation
(As of July 31, 2025)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Nestle SA Cl N | International Equity | Consumer Goods | Other European | 1.76% |
| Allianz SE | International Equity | Financial Services | European Union | 1.57% |
| Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 1.51% |
| ASML Holding NV | International Equity | Technology | European Union | 1.47% |
| Commonwealth Bank of Australia | International Equity | Financial Services | Asia/Pacific Rim | 1.40% |
| Sap SE | International Equity | Technology | European Union | 1.34% |
| Safran SA | International Equity | Industrial Goods | European Union | 1.33% |
| L'Air Liquide SA | International Equity | Basic Materials | European Union | 1.29% |
| UBS Group AG | International Equity | Financial Services | Other European | 1.29% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 1.28% |
Performance Data
(As of July 31, 2025)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-0.95
|
5.14
|
7.81
|
14.60
|
12.84
|
16.28
|
10.83
|
5.43
|
|
Benchmark
|
0.51
|
7.24
|
8.41
|
14.61
|
13.37
|
16.10
|
10.55
|
6.83
|
|
Quartile Ranking
|
3
|
2
|
1
|
1
|
2
|
1
|
1
|
3
|
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|
Fund
|
13.03
|
15.07
|
-8.20
|
9.45
|
2.69
|
12.19
|
-10.06
|
15.45
|
-2.80
|
13.37
|
|
Benchmark
|
11.18
|
15.74
|
-10.67
|
8.97
|
8.01
|
16.27
|
-6.81
|
18.37
|
-1.70
|
19.41
|
|
Quartile Ranking
|
2
|
2
|
2
|
2
|
3
|
4
|
3
|
3
|
3
|
3
|